Faecal Microbiota Transplant: A New

被引:1
|
作者
Thakur, Ankita [1 ,3 ]
Acharya, Sourya [1 ]
Shukla, Samarth [2 ]
机构
[1] Deemed Univ, Datta Meghe Inst Med Sci, Dept Internal Med, Wardha, Maharashtra, India
[2] Deemed Univ, Datta Meghe Inst Med Sci, Dept Pathol, Wardha, Maharashtra, India
[3] Deemed Univ, Datta Meghe Inst Med Sci, Wardha, Maharashtra, India
关键词
Autism; Metabolic syndrome; Microbiome; Pseudomembranous colitis; INTESTINAL MICROBIOTA; THERAPY; HISTORY;
D O I
10.7860/JCDR/2023/59214.17737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Faecal Microbiota Transplantation (FMT) refers to the process of introducing the gut microbiome into a compromised patient's Gastrointestinal (GI) tract after obtaining it from a healthy donor. It is one of the chief treatment options for people afflicted with a chronic Clostridium difficile infection. Recently, other possible applications of FMT have been gaining worldwide consideration as an emerging approach to treat a multitude of disorders, such as metabolic syndrome, neurological diseases like autism, Inflammatory Bowel Disease (IBD), and so on. FMT is not currently being used in clinical practice due to practical objections though research on how to overcome the same is ongoing. This article seeks to explore FMT as a procedure, its current indication and the results from various studies, applications of FMT as a course of treatment in other diseases, and the limitations that the procedure poses for the same, upon which further studies can commence and advancements can be made in the field of medicine.
引用
收藏
页码:OE1 / OE4
页数:4
相关论文
共 50 条
  • [21] Faecal microbiota transplantation
    Nieuwdorp, M.
    BRITISH JOURNAL OF SURGERY, 2014, 101 (08) : 887 - 888
  • [22] Faecal microbiota transplantation: more screening for old and new pathogens
    Hohmann, Elizabeth L.
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : 587 - 589
  • [23] Faecal Microbiota Transplant in Ulcerative Colitis (FMTUC) - A randomised clinical trial feasibility study
    Jitsumura, M.
    Cunningham, A.
    Hitchings, M. D.
    Wilkinson, T.
    Kinross, J.
    Row, P.
    Davies, A.
    Anthony, H. Dean
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I612 - I613
  • [24] FAECAL MICROBIOTA TRANSPLANT IN ULCERATIVE COLITIS (FMTUC) - A RANDOMISED CLINICAL TRIAL FEASIBILITY STUDY
    Jitsumura, Maki
    Cunningham, Andrew
    Hitchings, Matthew D.
    Wilkinson, Thomas
    Kinross, James W.
    Row, Paula
    Davies, Angharad
    Harris, Dean
    GASTROENTEROLOGY, 2022, 162 (07) : S982 - S982
  • [25] Faecal Microbiota Transplant in Ulcerative Colitis (FMTUC) - A randomised clinical trial feasibility study
    Jitsumura, M.
    Cunningham, A.
    Hitchings, M. D.
    Wilkinson, T.
    Kinross, J.
    Row, P.
    Davies, A.
    Anthony, H. Dean
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I612 - I613
  • [26] Results of the first paediatric randomised controlled trial of faecal microbiota transplant for ulcerative colitis
    Pai, N.
    Popov, J.
    Hill, L.
    Hartung, E.
    Grzywacz, K.
    Godin, D.
    Thabane, L.
    Lee, C.
    Khan, W.
    Surette, M.
    Moayyedi, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S379 - S379
  • [27] Just a gut feeling: Faecal microbiota transplant for treatment of depression - A mini-review
    Chang, Minna
    Chang, Kai Tuomas
    Chang, Fuju
    JOURNAL OF PSYCHOPHARMACOLOGY, 2024, 38 (04) : 353 - 361
  • [28] A core transferable microbiota in responders to faecal microbiota transplant for ulcerative colitis shape mucosal T-cell immunity
    Gogokhia, L.
    Lima, S.
    Viladomiu, M.
    Gerardin, Y.
    Crawford, C.
    Jacob, V.
    Scherl, E.
    Rosenthal, M.
    Brown, S. E.
    Hambor, J.
    Longman, R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S040 - S040
  • [29] Talking faecal transplant
    Mohammadi, Dara
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (01): : 12 - 12
  • [30] Faecal microbiota transplantation for NAFLD
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (08): : 728 - 728